CommercialPrior AuthHigh impact
Genetic Testing Update
Blue Cross Blue Shield of Nebraska·NE · Oncology, Cardiology, Gastroenterology +1 more·Medical Policy
Effective date
Jul 1, 2025
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Nebraska is implementing comprehensive genetic and specialty testing policy updates requiring preauthorization for multiple oncology tests, cardiovascular genetic panels, gastroenterology tests, and new heart transplant monitoring tests. All policies require preauthorization and have specific medical necessity criteria that must be met for coverage.
Action Required
By July 1, 2025: Billing team must update prior authorization requirements for all genetic testing, oncology algorithmic assays, cardiovascular genetic panels, liver fibrosis tests, and heart transplant gene expression panels for Blue Cross Blue Shield of Nebraska patients. Update billing system to flag these services for preauth verification. Train staff on new medical necessity criteria for each test type. Claims submitted without proper preauthorization will be denied.